Loading…

HOXA13 is associated with unfavorable survival and acts as a novel oncogene in prostate carcinoma

To investigate the clinical relevance and functional role of HOXA13 in prostate cancer Methods: PCR, western blot and immunohistochemistry were performed to determine the expression. Kaplan-Meier and Cox regression survival analyses investigated the clinical relevance. Cell viability, flow cytometry...

Full description

Saved in:
Bibliographic Details
Published in:Future oncology (London, England) England), 2017-07, Vol.13 (17), p.1505-1516
Main Authors: Dong, Yan, Cai, Ying, Liu, Bo, Jiao, Xiang, Li, Zhong-Tai, Guo, Da-Yong, Li, Xin-Wei, Wang, Yong-Jun, Yang, Deng-Ke
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To investigate the clinical relevance and functional role of HOXA13 in prostate cancer Methods: PCR, western blot and immunohistochemistry were performed to determine the expression. Kaplan-Meier and Cox regression survival analyses investigated the clinical relevance. Cell viability, flow cytometry and transwell assays were used to determine the functional roles. HOXA13 expression is sharply increased in carcinoma tissues and is significantly associated with poor prognosis of prostate cancer patients. Interestingly, nucleus not cytoplasm HOXA13 expression is associated with unfavorable survival of the patients. Furthermore, nucleus HOXA13 expression represents an unfavorable and independent prognosis factor of histological grade 2 or Gleason grade
ISSN:1479-6694
1744-8301
DOI:10.2217/fon-2016-0522